Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 2.1 EX-2.1
- 2.1 EX-2.1
- 2.1 EX-2.1
- 2.1 EX-2.1
- 3.1 EX-3.1
- 4.3 EX-4.3
- 4.5 EX-4.5
- 4.3 EX-4.3
- 5.1 EX-5.1
- 10.2 EX-10.2
- 10.2 EX-10.2
- 10.2 EX-10.2
- 10.1 EX-10.1
- 10.3 EX-10.3
- 16.1 EX-16.1
- 21.1 EX-21.1
- 23.2 EX-23.2
- 23.3 EX-23.3
- EX-FILING FEES Ex-filing Fees
- Download Excel data file
- View Excel data file
Associated filings
EUDA similar filings
Filing view
External links
Exhibit 16.1
1185 Avenue of the Americas, 38th Floor | ||
New York, NY 10036-2603 | ||
Phone | 212-381-4800 | |
Fax | 212-381-4811 | |
Web | www.uhy-us.com |
November 23, 2022
Office of the Chief Accountant
Securities and Exchange Commission
460 Fifth Street N. W.
Washington, DC 20549
Re: EUDA Health Holdings Limited
Ladies and Gentlemen:
We have read Item 4.01 of Form 8-K filed with the U.S. Securities and Exchange Commission on November 23, 2022 of EUDA Health Holdings Limited (the “Company”) and agree with the statements relating only to UHY LLP contained therein. We have no basis to agree or disagree with other statements of the Company contained therein.
We hereby consent to the filing of this letter as an exhibit to the foregoing report on Form 8-K.
Sincerely, | |
/s/ UHY LLP |